Skip to main content

Journal Club

Our global experts summarize key findings from the latest clinical trials in a half-hour weekly virtual presentation and panel discussion. Our insights help viewers integrate the latest information into their clinical practice in this constantly evolving field.

Filter

Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial with Gregg Stone

An interatrial shunt may provide an autoregulatory mechanism to decrease left atrial pressure and improve heart failure (HF) symptoms and prognosis. Patients with symptomatic HF with any left ventricular ejection…
December 14, 2024 Read More

Filter

Quality of Life after Transcatheter Tricuspid Valve Replacement: Results from the TRISCEND II Pivotal Trial with Suzanne Arnold

Severe tricuspid regurgitation (TR) often causes substantial impairment in patient-reported health status (ie, symptoms, physical and social function, and quality of life), which may improve with transcatheter tricuspid valve replacement…
December 7, 2024

CLEAR SYNERGY OASIS 9, A Randomized Trial of Colchicine and Spironolactone in Acute Myocardial Infarction with Sanjit S. Jolly

with Dr. Sanjit S. Jolly Patients experiencing myocardial infarction (MI) remain at high risk of future major adverse cardiovascular events (MACE). While low-dose colchicine and spironolactone have been shown to…
November 16, 2024

OCT-Imaging Predictors of Clinical Outcomes, the ILUMIEN IV: Optimal PCI with Ziad Ali

with Ziad A Ali MD DPhil Each week, we present a journal club in which we choose a study that we believe will be of interest to the interventional cardiology…
November 9, 2024

Invasive Treatment Strategy for Older Patients with Myocardial Infarction (the SENIOR-RITA trial) with Vijay Kunadian

In older adults with NSTEMI, an invasive strategy did not result in a significantly lower risk of cardiovascular death or nonfatal myocardial infarction (the composite primary outcome) than a conservative…
November 2, 2024

Revascularization for Ischemic Cardiomyopathy with Divaka Perera

with Dr. Divaka Perera Complete revascularization of coronary artery disease has been linked to improved outcomes in patients with preserved left ventricular (LV) function. Read more about the study here.
October 26, 2024

Reconsidering the Direction of Coronary Revascularization Trials with Gregg W. Stone

PCI vs. CABG in Women and Under-represented Minority Patients Assessed with a Novel Primary Endpoint: The RECHARGE Clinical Trial Program Gregg W. Stone MD The Zena and Michael A. Wiener…
October 12, 2024

Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease (the EPIC-CAD trial) with Duk-Woo Park

In patients with atrial fibrillation and stable coronary artery disease, edoxaban monotherapy led to a lower risk of a composite of death from any cause, myocardial infarction, stroke, systemic embolism,…
October 5, 2024

Transcatheter Repair vs. Mitral Valve Surgery for Secondary Mitral Regurgitation (the MATTERHORN trial) with Stephan Baldus

September 28, 2024

Transcatheter Valve Repair in Heart Failure with Moderate to Severe Regurgitation (the RESHAPE-HF2 trial) with Stefan Anker

Among patients with heart failure with moderate to severe functional mitral regurgitation who received medical therapy, the addition of transcatheter mitral-valve repair led to a lower rate of first or…
September 21, 2024

ORBITA-STAR trial and the ORBITA II Symptoms Analysis with Rasha Al-Lamee, Chris Rajkumar, and Florentina Simader

In stable coronary artery disease, 30% to 60% of patients remain symptomatic despite successful revascularization. Perhaps not all symptoms reported by a patient with myocardial ischemia are, in fact, angina.…
August 17, 2024